← TickerEye

0J8P.LIDEXX Laboratories, Inc.

Action·LSE·£

£533,53+2.19%
...
Plus haut£538,34
Plus bas£504,08
Volume96

À propos

IDEXX Laboratories, Inc. is a global enterprise dedicated to creating, producing, and distributing a broad spectrum of products and services. Its primary focus lies in serving the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company delivers crucial solutions across several key areas. For companion animals, IDEXX offers comprehensive veterinary diagnostic tools, including in-clinic point-of-care instruments, consumables, and rapid assay test kits. They also provide expert veterinary reference laboratory diagnostics, consulting services, and advanced practice management and diagnostic imaging systems. Beyond pets, their portfolio extends to health monitoring and diagnostic products vital for livestock, poultry, and dairy farming. In the water quality segment, IDEXX manufactures tests designed to detect various microbiological contaminants, ensuring safety and compliance, with notable examples like the Colilert, Enterolert, and Legiolert tests. IDEXX also serves the biomedical research community with health monitoring and laboratory animal diagnostic instruments and services. Furthermore, they contribute to human point-of-care medical diagnostics by providing specialized electrolytes and blood gas analyzers, alongside SARS-CoV-2 RT-PCR solutions. Their extensive product lineup features various in-clinic chemistry, blood, and urine analyzers (such as the SediVue Dx), hematology systems, and rapid diagnostic assays like SNAP test kits. Complementing these offerings, the company provides essential veterinary software solutions for both independent and corporate veterinary practices. Sales and distribution are managed through their dedicated marketing, customer service, sales, and technical support teams, supplemented by a network of independent distributors and other resellers. Established in 1983, IDEXX Laboratories, Inc. maintains its headquarters in Westbrook, Maine.

www.idexx.com

Statistiques clés

Capitalisation
42.09B
BPA
13.17
Rendement dividende
0.00%
Bêta
1.54
P/B
34.09
ROE
66.0%
Secteur
Healthcare
Industrie
Medical - Diagnostics & Research
PDG
Jonathan J. Mazelsky
Employés
11 000
Date IPO
2018-01-19
Pays
US

Suivez en direct avec TickerEye

Voyez le prix de 0J8P.L en direct sur votre écran physique. Alertes via apps iOS et Android.